Literature DB >> 21126579

Glycosylation of the OCTN2 carnitine transporter: study of natural mutations identified in patients with primary carnitine deficiency.

Cristina Amat di San Filippo1, Orly Ardon, Nicola Longo.   

Abstract

Primary carnitine deficiency is caused by impaired activity of the Na(+)-dependent OCTN2 carnitine/organic cation transporter. Carnitine is essential for entry of long-chain fatty acids into mitochondria and its deficiency impairs fatty acid oxidation. Most missense mutations identified in patients with primary carnitine deficiency affect putative transmembrane or intracellular domains of the transporter. Exceptions are the substitutions P46S and R83L located in an extracellular loop close to putative glycosylation sites (N57, N64, and N91) of OCTN2. P46S and R83L impaired glycosylation and maturation of OCTN2 transporters to the plasma membrane. We tested whether glycosylation was essential for the maturation of OCTN2 transporters to the plasma membrane. Substitution of each of the three asparagine (N) glycosylation sites with glutamine (Q) decreased carnitine transport. Substitution of two sites at a time caused a further decline in carnitine transport that was fully abolished when all three glycosylation sites were substituted by glutamine (N57Q/N64Q/N91Q). Kinetic analysis of carnitine and sodium-stimulated carnitine transport indicated that all substitutions decreased the Vmax for carnitine transport, but N64Q/N91Q also significantly increased the Km toward carnitine, indicating that these two substitutions affected regions of the transporter important for substrate recognition. Western blot analysis confirmed increased mobility of OCTN2 transporters with progressive substitutions of asparagines 57, 64 and/or 91 with glutamine. Confocal microscopy indicated that glutamine substitutions caused progressive retention of OCTN2 transporters in the cytoplasm, up to full retention (such as that observed with R83L) when all three glycosylation sites were substituted. Tunicamycin prevented OCTN2 glycosylation, but it did not impair maturation to the plasma membrane. These results indicate that OCTN2 is physiologically glycosylated and that the P46S and R83L substitutions impair this process. Glycosylation does not affect maturation of OCTN2 transporters to the plasma membrane, but the 3 asparagines that are normally glycosylated are located in a region important for substrate recognition and turnover rate. Copyright Â
© 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21126579      PMCID: PMC3026072          DOI: 10.1016/j.bbadis.2010.11.007

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  21 in total

Review 1.  Structure of renal organic anion and cation transporters.

Authors:  G Burckhardt; N A Wolff
Journal:  Am J Physiol Renal Physiol       Date:  2000-06

2.  The role of N-linked glycosylation in protein folding, membrane targeting, and substrate binding of human organic anion transporter hOAT4.

Authors:  Fanfan Zhou; Wen Xu; Mei Hong; Zui Pan; Patrick J Sinko; Jianjie Ma; Guofeng You
Journal:  Mol Pharmacol       Date:  2004-12-02       Impact factor: 4.436

3.  Carnitine transporter defect due to a novel mutation in the SLC22A5 gene presenting with peripheral neuropathy.

Authors:  N Makhseed; H D Vallance; M Potter; P J Waters; L T K Wong; Y Lillquist; M Pasquali; C Amat di San Filippo; N Longo
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

4.  Mutations in novel organic cation transporter (OCTN2), an organic cation/carnitine transporter, with differential effects on the organic cation transport function and the carnitine transport function.

Authors:  P Seth; X Wu; W Huang; F H Leibach; V Ganapathy
Journal:  J Biol Chem       Date:  1999-11-19       Impact factor: 5.157

5.  A missense mutation in the OCTN2 gene associated with residual carnitine transport activity.

Authors:  Y Wang; M A Kelly; T M Cowan; N Longo
Journal:  Hum Mutat       Date:  2000       Impact factor: 4.878

Review 6.  Disorders of carnitine transport and the carnitine cycle.

Authors:  Nicola Longo; Cristina Amat di San Filippo; Marzia Pasquali
Journal:  Am J Med Genet C Semin Med Genet       Date:  2006-05-15       Impact factor: 3.908

Review 7.  Molecular insights into the structure-function relationship of organic anion transporters OATs.

Authors:  Fanfan Zhou; Guofeng You
Journal:  Pharm Res       Date:  2006-11-14       Impact factor: 4.200

8.  Expanded newborn screening identifies maternal primary carnitine deficiency.

Authors:  Lisa A Schimmenti; Eric A Crombez; Bernd C Schwahn; Bryce A Heese; Timothy C Wood; Richard J Schroer; Kristi Bentler; Stephen Cederbaum; Kiki Sarafoglou; Mark McCann; Piero Rinaldo; Dietrich Matern; Cristina Amat di San Filippo; Marzia Pasquali; Susan A Berry; Nicola Longo
Journal:  Mol Genet Metab       Date:  2006-11-28       Impact factor: 4.797

9.  Pharmacological rescue of carnitine transport in primary carnitine deficiency.

Authors:  Cristina Amat di San Filippo; Marzia Pasquali; Nicola Longo
Journal:  Hum Mutat       Date:  2006-06       Impact factor: 4.878

10.  OCTN2VT, a splice variant of OCTN2, does not transport carnitine because of the retention in the endoplasmic reticulum caused by insertion of 24 amino acids in the first extracellular loop of OCTN2.

Authors:  Satoshi Maekawa; Daisuke Mori; Tadashi Nishiya; Osamu Takikawa; Takahiro Horinouchi; Arata Nishimoto; Emi Kajita; Soichi Miwa
Journal:  Biochim Biophys Acta       Date:  2007-04-19
View more
  17 in total

1.  Primary Carnitine (OCTN2) Deficiency Without Neonatal Carnitine Deficiency.

Authors:  L de Boer; L A J Kluijtmans; E Morava
Journal:  JIMD Rep       Date:  2012-12-29

2.  Functional and molecular studies in primary carnitine deficiency.

Authors:  Marta Frigeni; Bijina Balakrishnan; Xue Yin; Fernanda R O Calderon; Rong Mao; Marzia Pasquali; Nicola Longo
Journal:  Hum Mutat       Date:  2017-09-14       Impact factor: 4.878

3.  Genotype-phenotype correlation in primary carnitine deficiency.

Authors:  Emily C Rose; Cristina Amat di San Filippo; Uzochi C Ndukwe Erlingsson; Orly Ardon; Marzia Pasquali; Nicola Longo
Journal:  Hum Mutat       Date:  2011-10-11       Impact factor: 4.878

Review 4.  Loops and layers of post-translational modifications of drug transporters.

Authors:  Da Xu; Guofeng You
Journal:  Adv Drug Deliv Rev       Date:  2016-05-09       Impact factor: 15.470

5.  Uptake Assays to Monitor Anthracyclines Entry into Mammalian Cells.

Authors:  Nicolas Brosseau; Emil Andreev; Dindial Ramotar
Journal:  Bio Protoc       Date:  2017-09-20

6.  Wide tolerance to amino acids substitutions in the OCTN1 ergothioneine transporter.

Authors:  Marta Frigeni; Francesco Iacobazzi; Xue Yin; Nicola Longo
Journal:  Biochim Biophys Acta       Date:  2016-03-16

Review 7.  Carnitine transport and fatty acid oxidation.

Authors:  Nicola Longo; Marta Frigeni; Marzia Pasquali
Journal:  Biochim Biophys Acta       Date:  2016-01-29

8.  Newborn screening for carnitine transporter defect in Bavaria and the long-term follow-up of the identified newborns and mothers: Assessing the benefit and possible harm based on 19 ½ years of experience.

Authors:  Katharina A Schiergens; Katharina J Weiss; Wulf Röschinger; Amelie S Lotz-Havla; Joachim Schmitt; Robert Dalla Pozza; Sarah Ulrich; Birgit Odenwald; Joachim Kreuder; Esther M Maier
Journal:  Mol Genet Metab Rep       Date:  2021-06-12

Review 9.  Strategies of bacterial over expression of membrane transporters relevant in human health: the successful case of the three members of OCTN subfamily.

Authors:  Cesare Indiveri; Michele Galluccio; Mariafrancesca Scalise; Lorena Pochini
Journal:  Mol Biotechnol       Date:  2013-06       Impact factor: 2.695

Review 10.  Systemic primary carnitine deficiency: an overview of clinical manifestations, diagnosis, and management.

Authors:  Pilar L Magoulas; Ayman W El-Hattab
Journal:  Orphanet J Rare Dis       Date:  2012-09-18       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.